ACHE and schistosomiasis: The results obtained further support the potential of AChE as a future drug or vaccine target against S. japonicum infection and also strengthen the view that immunological targeting of schistosome AChEs may be a suitable avenue for developing future treatments and the prevention of schistosomiasis.